戈利穆马布用于多关节性青春性异常性关节炎和牛皮性关节炎:药理和临床考虑
Sydney Moore McIntosh1, Christian Kerut2, Payton P Hollenshead1
1School of Medicine, Louisiana State University Health Sciences Center at Shreveport, Shreveport, LA 71103, USA.
Life (Basel, Switzerland)
|July 29, 2023
概括
戈利穆马布有效治疗牛皮关节炎和多关节性青少年异常性关节炎在2至17岁及成年患者中. 这种瘤亡因子-α阻断剂在研究中显示了最小的不良事件.
科学领域:
- 免疫学 免疫学 免疫学
- 类风湿病学 类风湿病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 牛皮关节炎 (PsA) 是一种具有明显皮肤表现的慢性自身免疫性疾病.
- 瘤亡因子-α (TNF-a) 的升高与PsA的发病有关.
- 现有的治疗方法提供了各种选择,其中抗TNF疗法是基石.
研究的目的:
- 评估golimumab在治疗成人和儿童牛皮性关节炎,包括多关节性青少年异常性关节炎 (pJIA) 的疗效.
- 为了比较golimumab的有效性与当前的治疗选择.
- 评估不同患者群体中与戈利穆马布相关的安全性和不良事件.
主要方法:
- 对四项研究进行了元分析.
- 研究包括儿科患者 (2-17岁) 和成人患者 (18-83岁).
- 戈利穆马布的疗效和不良事件与现有治疗方法进行了比较,包括阿达利穆马布.
主要成果:
- 戈利马布在治疗活跃的牛皮关节炎和pJIA方面表现出显著的疗效.
- 这种药物在对阿达利姆巴药物反应不足的患者中被证明是有效的.
- 报告了最小的不良事件,表明了有利的安全概况,包括在儿科患者群体.
结论:
- 戈利穆马布是牛皮关节炎和pJIA的有效治疗选择.
- 它为那些对其他疗法没有反应的患者提供了安全有效的替代方案.
- 该药物的安全性支持其在儿童和成人患者中使用.
相关概念视频
Inflammatory Bowel Disease IV: Pharmacological Management
152
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
152
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
173
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
173
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
195
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
195
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
153
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
153
Rheumatic Heart Disease III: Medical Management
20
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
20
Pericarditis III: Medical Management
15
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
15


